Search results for "Highlights"


 
Results 21 - 30 of about 166 for "Highlights".
Sort by: Relevance | Newest | Oldest

Pandemic may have led to later presentation of colorectal, breast cancers

A single-center study in California found that more patients presented with stage I disease and fewer presented with stage IV disease in 2019 versus 2020, but the changes were statistically significant only for breast cancer.
https://gastroenterology.acponline.org/archives/2022/02/25/3.htm
25 Feb 2022

Cost may be common factor in drug nonadherence among patients with chronic liver disease

About 25% of 3,237 respondents with chronic liver disease in the National Health Interview Survey from 2014 through 2018 reported not taking their medications as prescribed due to cost.
https://gastroenterology.acponline.org/archives/2021/06/25/4.htm
25 Jun 2021

HCV medications decreased liver disease among those using injection drugs

A Baltimore-based study found that half of participants with chronic hepatitis C virus (HCV) and a history of injection drug use at baseline were free of the virus by 2019, with associated reductions in their risk of cirrhosis and mortality.
https://gastroenterology.acponline.org/archives/2022/07/22/2.htm
22 Jul 2022

Spotlight on The Liver Meeting

Highlights from the American Association for the Study of Liver Diseases' annual meeting, held virtually this past weekend, included insights on COVID-19 and the liver and a conversation with the winners of the Nobel Prize in Physiology or Medicine 2020, who discovered hepatitis C virus.
https://gastroenterology.acponline.org/archives/2020/11/20/5.htm
20 Nov 2020

DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds

Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://gastroenterology.acponline.org/archives/2022/07/22/6.htm
22 Jul 2022

GI bleeding risks with warfarin and DOACs compared

Warfarin was associated with a similar risk of lower GI bleeding as direct oral anticoagulants (DOACs) but more than twice the rate of upper GI bleeding, which led study authors to suggest that DOACs may be preferable to warfarin in patients at high risk of upper GI bleeds.
https://gastroenterology.acponline.org/archives/2022/08/26/1.htm
26 Aug 2022

H. pylori eradication therapy may lead to better outcomes for functional dyspepsia

A systematic review and meta-analysis found that Helicobacter pylori eradication therapy was associated with higher cure rates and rates of symptom improvement in H. pylori-positive patients with functional dyspepsia.
https://gastroenterology.acponline.org/archives/2022/01/28/2.htm
28 Jan 2022

Fatty liver disease may not affect mortality risk in elderly patients

In a Dutch cohort study of patients ages 65 years and older, no association was found between hepatic steatosis and death in the overall population or in clinically relevant subgroups.
https://gastroenterology.acponline.org/archives/2022/07/22/3.htm
22 Jul 2022

Electronic alert about lactulose linked to lower readmissions in patients with cirrhosis

The alert, which encouraged clinicians to prescribe rifaximin for patients with cirrhosis and hepatic encephalopathy who were on lactulose, increased uptake of rifaximin in such patients.
https://gastroenterology.acponline.org/archives/2022/01/28/3.htm
28 Jan 2022

Biologics found to be effective for ulcerative colitis in industry-funded trials

An editorial said the results highlight the importance of alternative biologic treatments and regimens for some patients but noted that further research is needed on cost-effectiveness.
https://gastroenterology.acponline.org/archives/2019/09/27/2.htm
27 Sep 2019

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next